The following page is designed to provide participating New IDEAS dementia practices and PET imaging facilities updates on study activities. This page will be updated monthly.
Please contact the New IDEAS Operations Team at newideas@acr.org with any questions about the updates featuring on this page or past updates.
Note: Data reflects patient registrations. Total scans may not exceed cohort maximums defined by the study protocol.
Read the most recent New IDEAS Study Newsletter here to learn more about ongoing initiatives. Read the most recent newsletter or past newsletters.
After careful consideration of numerous factors and evaluation of the risk-benefit tradeoff for patients, Study leadership has decided to end Study accrual on Friday, March 1, 2024 at 11:59pm EST. At that time, patient registration into the Study Portal will be closed. This deadline is applicable to all race/ethnicity cohorts of the Study. This decision was difficult; however, Study leadership is confident that this is the best course of action based on the following factors:
For more information, please read the full official Study Closure Memorandum and Study Closure Guide and Frequently Asked Questions for more information and next steps for your dementia practice or PET imaging facility.
Please direct any questions or concerns to newideas@acr.org.
The New IDEAS Study protocol was initially approved as a Coverage with Evidence Development (CED) Study under the supervision of the Centers for Medicare & Medicaid Services (CMS). On October 13, 2023, CMS issued a public announcement that retired the National Coverage Determination (NCD) on amyloid PET and ended CED as a criterion for coverage of amyloid PET scans. As a result of the retirement of the NCD, the CED is no longer applicable to the New IDEAS Study. Please review the following important information:
Please direct any questions or concerns to newideas@acr.org.
The Study Sponsor has obtained IRB approval for a patient-facing notice explaining changes to CED in lay terminology. This notice has been approved for all IRB-approved sites, with site-level approval letters accessible in the Advarra IRB CIRBI Portal. Upon receiving site-level approval for the patient-facing letter, sites must:
1. Log in to the CIRBI Portal, download the patient-facing letter from the "IRB Issued Documents" section.
2. Disseminate the letter to already consented patients awaiting PET scans and those interested in participating.
3. File a copy of the document in the protocol file.
Effective September 2023, Lecanemab was added as an anti-amyloid pharma therapy option on the Pre-PET and Post-PET forms. Please review and download the latest version of the Case Report Form Packet for Dementia Practices. These changes are currently live in the New IDEAS Portal.
Effective September 1, 2023, the New IDEAS Study Team will re-open the “All Other Races/Ethnicities” cohort to only those sites who have registered at least ten (10) participants since March 1, 2022 (Note: Registrations must represent 10 unique individuals, not re-registrations).
Please review the following transmittals and MLN articles regarding NCD 220.6.20 - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease. Transmittal R12364CP and R12364NCD and MM13429 (Released November 16, 2023). Please contact newideas@acr.org with any questions.
If your facility is currently experiencing issues with prior authorization requests or Medicare reimbursement for amyloid PET scans conducted through New IDEAS, please contact the New IDEAS Operations Team at newideas@acr.org.
Detailed instructions on proper Medicare billing processes can be found on the study website. Reminder, the study has a template letter available for use when communicating with Medicare Advantage Plans. This resource has been proven successful in obtaining prior authorization for coverage
New IDEAS Study Champions attended the Delta Sigma Theta Sorority Heath & Wellness Expo near Dallas in March to share information about the study and the importance of memory care.
Study Champions are trained volunteers who partner with community organizations within their region to spread information about the New IDEAS Study. Champions must live in near one of the following metropolitan areas - Chicago, Dallas, Houston, Los Angeles, Miami, Philadelphia/New Jersey, San Diego, Washington DC/DMV.
If you become a Study Champion, you will receive training on New IDEAS and learn how to build strong community relationships and cultural humility.
Email NewIdeasStudy.CES@med.unc.edu to learn more about becoming a New IDEAS Study Champion.
Page last updated: March 4, 2024